Quantcast

Celimmune launches effort on celiac treatment

Celimmune, of Bethesda, a new pharmaceutical company focused on immune disorders, announced that its initial efforts will target celiac disease. Dr. Francisco Leon, Celimmune's CEO and chief medical officer, said in a statement: "Currently, there are no treatments approved for celiac disease, and the only management option is a strict, life-long, gluten-free diet, which severely ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*